A Food and Drug Administration study found that those who suffer from attention deficit hyperactivity disorder can take medications without increasing their risk of heart problems. The study focused on patients ages 2 through 24.

Medical News Today reports the massive study, published in the New England Journal of Medicine, found few serious cases of cardiovascular issues in patients taking amphetamine (Adderrall), methylphenidate (Ritalin), atomoxetine (Strattera) and pemoline (Betanamin).

The FDA offers this advice for those with ADHD:

* Continue your ADHD treatment as prescribed by a healthcare professional.

* Talk to your healthcare professional about any questions you may have about ADHD medications.

* Immediately see a healthcare professional if you or the person you are caring for develops chest pain, shortness of breath, or fainting while taking medication to treat ADHD.

* Report any suspected side effects of ADHD medication use to your healthcare professional or to the FDA MedWatch program.

FDA Says ADHD Medications Are OK [Medical News Today]

Want more consumer news? Visit our parent organization, Consumer Reports, for the latest on scams, recalls, and other consumer issues.